Short Interest in Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Expands By 104.2%

Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 187,743 shares, an increase of 104.2% from the December 31st total of 91,944 shares. Currently, 0.6% of the shares of the company are sold short. Based on an average daily trading volume, of 140,712 shares, the short-interest ratio is currently 1.3 days. Based on an average daily trading volume, of 140,712 shares, the short-interest ratio is currently 1.3 days. Currently, 0.6% of the shares of the company are sold short.

Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund

Institutional investors and hedge funds have recently modified their holdings of the company. MRA Advisory Group boosted its position in Neuberger Berman High Yield Strategies Fund by 10.9% in the third quarter. MRA Advisory Group now owns 17,261 shares of the investment management company’s stock valued at $129,000 after buying an additional 1,693 shares during the last quarter. Equitable Holdings Inc. boosted its holdings in shares of Neuberger Berman High Yield Strategies Fund by 7.3% in the 3rd quarter. Equitable Holdings Inc. now owns 49,343 shares of the investment management company’s stock valued at $370,000 after acquiring an additional 3,343 shares during the last quarter. SeaCrest Wealth Management LLC raised its holdings in shares of Neuberger Berman High Yield Strategies Fund by 14.0% during the third quarter. SeaCrest Wealth Management LLC now owns 42,369 shares of the investment management company’s stock worth $322,000 after purchasing an additional 5,219 shares during the last quarter. J.W. Cole Advisors Inc. boosted its holdings in Neuberger Berman High Yield Strategies Fund by 3.1% in the second quarter. J.W. Cole Advisors Inc. now owns 206,192 shares of the investment management company’s stock valued at $1,563,000 after purchasing an additional 6,237 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in Neuberger Berman High Yield Strategies Fund by 3.5% in the second quarter. Invesco Ltd. now owns 258,944 shares of the investment management company’s stock valued at $1,963,000 after purchasing an additional 8,676 shares during the last quarter.

Neuberger Berman High Yield Strategies Fund Price Performance

Shares of NHS opened at $7.60 on Friday. The company’s fifty day moving average price is $7.32 and its 200-day moving average price is $7.40. Neuberger Berman High Yield Strategies Fund has a 1-year low of $6.62 and a 1-year high of $7.94.

Neuberger Berman High Yield Strategies Fund Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Friday, January 30th. Stockholders of record on Thursday, January 15th were issued a $0.0905 dividend. The ex-dividend date of this dividend was Thursday, January 15th. This represents a c) dividend on an annualized basis and a dividend yield of 14.3%.

About Neuberger Berman High Yield Strategies Fund

The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.

Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.